ArticleThe Lancet regional health. Europe2022

Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34 years of age: A nationwide register-based study.

Jenny Niemeyer Hultstrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.